About: A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) ലേഖനം (ml) հոդված (hy) wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2000 (uk) article scientifique publié en 2000 (fr) im August 2000 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q56532851-A57FE8BA-83B0-4DD5-B762-00C366176AEF
publication date	2000-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56532851-F10F5C36-0FDF-45EF-A4D2-747C741864F0
language of work or name	English
cites work	wds:Q56532851-0676A051-CA86-4DB4-853D-05BD53176BB1 wds:Q56532851-080CCAED-2A82-42BB-A9FF-14D2636722F0 wds:Q56532851-10078FA2-99C4-4193-B1CA-0323066C5127 wds:Q56532851-101D773D-7F67-45CF-9949-28277A087C02 wds:Q56532851-16A2D3FC-473C-48FC-AF83-27682DF55B5C wds:Q56532851-178772AC-ECAF-466E-A1AD-1652D8CF785E wds:Q56532851-1AD8406D-F21C-4208-8ED2-2FAC5A7B2B38 wds:Q56532851-1C029898-DD66-4BB7-AC45-BE9D2DE99AF6 wds:Q56532851-1CAC7E45-9529-4E78-AF26-5E9A8FFD37FD wds:Q56532851-1EDF2C22-558D-4528-A997-9E9314505BA3 wds:Q56532851-20C64584-684A-4C60-8A09-A6EE131236A5 wds:Q56532851-2C6E5F79-351F-4286-A0E6-CB095A6A986B wds:Q56532851-2F369E86-2203-4452-940C-378C320FFAA5 wds:Q56532851-353A4193-5804-4AFC-B900-C963A2E6F9D0 wds:Q56532851-36BEEC15-CD38-477E-ADF2-0395B0C6FAAB wds:Q56532851-43BFB4A0-481C-445D-BA91-20F6274F80B7 wds:Q56532851-43E8D7D6-BD47-4C2C-9C8A-5EA847C2FECF wds:Q56532851-46AD1002-6488-479B-B360-E5F6C6DDE969 wds:Q56532851-4B718812-84F4-4755-AD9E-79D3AB13AB68 wds:Q56532851-53C1C416-10BA-41DA-BB8D-DA372BC03C39 wds:Q56532851-56BB52A8-D953-4B41-A7EC-6AEF60CD7FF4 wds:Q56532851-66DC1D2F-021B-4F37-A44A-F6C5341AC374 wds:Q56532851-67054932-C5C3-4BEE-9C8D-183E7075B6BF wds:Q56532851-67304A66-2354-4CC5-9861-31D346A20D5C wds:Q56532851-6EAAC6CA-BB88-486F-AAF8-E198DB4644F7 wds:Q56532851-7AD2A158-7441-49F3-BF22-1B82F15D9D9E wds:Q56532851-8601F9BC-34E2-4AED-A7B8-E4DF80F70996 wds:Q56532851-93E972C6-028A-41AA-9619-D4207FCC0CDD wds:Q56532851-A9395DE7-7901-4507-8968-33865D4C347B wds:Q56532851-B064F890-45BD-4B90-B555-5EFD56B61D16 wds:Q56532851-B62DBF5D-E0E2-4F39-95D3-F65F54ABD612 wds:Q56532851-CC173FAA-B668-441F-960C-E251CD552820 wds:Q56532851-DEB40896-C8BE-4B5B-88FD-1A70C8FD7745 wds:Q56532851-EFA2BA35-13A4-4769-A9C8-6FFD14CACABD wds:Q56532851-F8597542-43E4-4508-925F-775648BD8C74
cites work	A Multiple Comparison Procedure for Comparing Several Treatments with a Control Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Nonparametric Estimation from Incomplete Observations The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity Altered fractionation trials in head and neck cancer Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck Biologic basis for altered fractionation schemes. The randomization and stratification of patients to clinical trials Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes Twice-a-day radiation therapy for supraglottic carcinoma ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313 Twice-a-day radiation therapy for cancer of the head and neck Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Onc Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Monoclonal antibodies as potentiators of radiotherapy and chemotherapy in the management of head and neck cancer Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity Toxicity antagonists in cancer therapy. Designing clinical trials for two-sided multiple comparisons with a control.
author name string	wds:Q56532851-016A5A7B-6437-41DD-87EB-FBFBD79EA5DB wds:Q56532851-4139D801-1E7B-4BFE-BC0D-19BF96D6570C wds:Q56532851-4510D452-65AF-4316-BAB6-C561A30E217D wds:Q56532851-499E41A4-B3E2-4921-87A4-53FE0FFC3AA7 wds:Q56532851-6A69FAC5-BB31-4054-A95F-DC7EA7A750FC wds:Q56532851-8ACFC9F5-B1B8-42DE-BC9B-8B7CABAF72F4 wds:Q56532851-9F6FD9F6-6FED-40C8-A376-344519C17B29 wds:Q56532851-FD070A82-1930-46CF-81A9-0ED9C9C0210E
author name string	S A Spencer J A Ridge K K Fu T L Phillips J S Cooper T F Pajak A Trotti C U Jones
rdfs:label	A radiation therapy oncology group (nl) A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9 (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software